Simplex Trading’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-46
Closed -$6K 9553
2023
Q3
$6K Hold
46
﹤0.01% 7557
2023
Q2
$8K Buy
46
+34
+283% +$6.8K ﹤0.01% 7601
2023
Q1
$2K Hold
12
﹤0.01% 8504
2022
Q4
$2K Sell
12
-2
-14% -$755 ﹤0.01% 8620
2022
Q3
$5K Buy
14
+9
+180% +$5.1K ﹤0.01% 8800
2022
Q2
$2K Sell
5
-9
-64% -$4.35K ﹤0.01% 9402
2022
Q1
$8K Sell
14
-19
-58% -$14.1K ﹤0.01% 9084
2021
Q4
$36K Sell
33
-3
-8% -$6.52K ﹤0.01% 7673
2021
Q3
$102K Hold
36
﹤0.01% 6597
2021
Q2
$104K Buy
+36
New +$85K ﹤0.01% 6675
2021
Q1
Hold
0
6247

Other funds holding PAVM

Simplex Trading's PAVM Position: Q1 2026 in Review

Simplex Trading sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 35 shares — an estimated $231 sold.

Simplex Trading first reported a position in PAVM in Q1 2021 and held it in 15 quarters. The position peaked at $85K in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Simplex Trading reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 35 PAVmed shares in Q1 2026, an estimated $231.
  • Simplex Trading first reported a position in PAVmed in Q1 2021 and held it in 15 quarters.
  • Simplex Trading's PAVmed position peaked at $85K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.